EPITHELIOID HAEMANGIOENDOTHELIOMA

Clinical trials for EPITHELIOID HAEMANGIOENDOTHELIOMA explained in plain language.

Never miss a new study

Get alerted when new EPITHELIOID HAEMANGIOENDOTHELIOMA trials appear

Sign up with your email to follow new studies for EPITHELIOID HAEMANGIOENDOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New pill targets cancer growth pathway in advanced tumors

Disease control Not yet recruiting

This study tests a new drug called TYK-01054 for people with advanced solid tumors that have not responded to standard treatments. The drug is taken as a capsule and works by blocking a protein (TEAD) involved in cancer growth. The trial will check safety, find the best dose, and…

Matched conditions: EPITHELIOID HAEMANGIOENDOTHELIOMA

Phase: PHASE1, PHASE2 • Sponsor: TYK Medicines, Inc • Aim: Disease control

Last updated Jun 27, 2026 08:06 UTC

EPITHELIOID HAEMANGIOENDOTHELIOMA

Get alerted when new EPITHELIOID HAEMANGIOENDOTHELIOMA trials appear

New pill targets cancer growth pathway in advanced tumors